144 related articles for article (PubMed ID: 37662747)
21. The predictive value of the preoperative albumin-to-fibrinogen ratio for postoperative hospital length of stay in liver cancer patients.
Li F; Ren Y; Fan J; Zhou J
Cancer Med; 2023 Oct; 12(20):20321-20331. PubMed ID: 37815011
[TBL] [Abstract][Full Text] [Related]
22. Albumin-to-fibrinogen ratio is an independent prognostic parameter in de novo non-M3 acute myeloid leukemia.
Ding Y; Qi X; Li Y; Sun Y; Wan J; Luo C; Huang Y; Li Q; Wu G; Zhu X; Xu S
Clin Exp Med; 2023 Dec; 23(8):4597-4608. PubMed ID: 37914966
[TBL] [Abstract][Full Text] [Related]
23. High Systemic Immune-Inflammation Index (SII) Represents an Unfavorable Prognostic Factor for Small Cell Lung Cancer Treated with Etoposide and Platinum-Based Chemotherapy.
Wang C; Jin S; Xu S; Cao S
Lung; 2020 Apr; 198(2):405-414. PubMed ID: 32016563
[TBL] [Abstract][Full Text] [Related]
24. Prognostic Significance of the Albumin to Fibrinogen Ratio in Peritoneal Dialysis Patients.
Xia W; Kuang M; Li C; Yao X; Chen Y; Lin J; Hu H
Front Med (Lausanne); 2022; 9():820281. PubMed ID: 35572991
[TBL] [Abstract][Full Text] [Related]
25. Prognostic Value of Albumin-to-Fibrinogen Ratio for 28-Day Mortality among Patients with Sepsis from Various Infection Sites.
Li S; Shen Y; Chang B; Wang N
Mediators Inflamm; 2022; 2022():3578528. PubMed ID: 35990041
[TBL] [Abstract][Full Text] [Related]
26. Prognostic Value of Combined Detection of Preoperative Albumin-to-Fibrinogen Ratio and Neutrophil-to-Lymphocyte Ratio in Operable Esophageal Squamous Cell Carcinoma Patients without Neoadjuvant Therapy.
Zheng Z; Lin D; Chen Q; Zheng B; Liang M; Chen C; Zheng W
Cancer Manag Res; 2021; 13():2359-2370. PubMed ID: 33737833
[TBL] [Abstract][Full Text] [Related]
27. Prognostic Significance of the Preoperative Albumin/Fibrinogen Ratio in Patients with Esophageal Squamous Cell Carcinoma after Surgical Resection.
Zhang H; Ren P; Ma M; Zhu X; Zhu K; Xiao W; Gong L; Tang P; Yu Z
J Cancer; 2021; 12(16):5025-5034. PubMed ID: 34234871
[No Abstract] [Full Text] [Related]
28. Prognostic role of pretreatment lung immune prognostic index in extensive-stage small-cell lung cancer treated with platinum plus etoposide chemotherapy.
Qi W; Zhao S; Chen J
Cancer Biomark; 2021; 31(2):177-185. PubMed ID: 33896825
[TBL] [Abstract][Full Text] [Related]
29. Prognostic value of baseline hemoglobin-to-red blood cell distribution width ratio in small cell lung cancer: A retrospective analysis.
Wu F; Yang S; Tang X; Liu W; Chen H; Gao H
Thorac Cancer; 2020 Apr; 11(4):888-897. PubMed ID: 32087605
[TBL] [Abstract][Full Text] [Related]
30. [First-line chemotherapy and its survival analysis of 394 patients with extensive-stage small cell lung cancer in a single institute].
Ma M; Wang M; Xu Y; Hu K; Liu H; Li L; Zhong W; Zhang L; Zhao J; Wang H
Zhongguo Fei Ai Za Zhi; 2014 Jan; 17(1):8-14. PubMed ID: 24398308
[TBL] [Abstract][Full Text] [Related]
31. Serum YKL-40 level is associated with the chemotherapy response and prognosis of patients with small cell lung cancer.
Xu CH; Yu LK; Hao KK
PLoS One; 2014; 9(5):e96384. PubMed ID: 24801872
[TBL] [Abstract][Full Text] [Related]
32. Combining Lactate Dehydrogenase and Fibrinogen: Potential Factors to Predict Therapeutic Efficacy and Prognosis of Patients with Small-Cell Lung Cancer.
Huang W; Liu P; Zong M; Chen QQ; Zhou H; Kong H; Xie WP
Cancer Manag Res; 2021; 13():4299-4307. PubMed ID: 34103985
[TBL] [Abstract][Full Text] [Related]
33. Prognostic Value of the Pretreatment Lung Immune Prognostic Index in Advanced Small Cell Lung Cancer Patients Treated With First-Line PD-1/PD-L1 Inhibitors Plus Chemotherapy.
Li L; Pi C; Yan X; Lu J; Yang X; Wang C; Li X; Zhang S; Zhang Z; Sun Y; Hu Y
Front Oncol; 2021; 11():697865. PubMed ID: 34692478
[TBL] [Abstract][Full Text] [Related]
34. Construction of the prognostic model for small-cell lung cancer based on inflammatory markers: A real-world study of 612 cases with eastern cooperative oncology group performance score 0-1.
Liu C; Jin B; Liu Y; Juhua O; Bao B; Yang B; Liu X; Yu P; Luo Y; Wang S; Teng Z; Song N; Qu J; Zhao J; Chen Y; Qu X; Zhang L
Cancer Med; 2023 Apr; 12(8):9527-9540. PubMed ID: 37015898
[TBL] [Abstract][Full Text] [Related]
35. Albumin-fibrinogen ratio and fibrinogen-prealbumin ratio as promising prognostic markers for cancers: an updated meta-analysis.
Sun DW; An L; Lv GY
World J Surg Oncol; 2020 Jan; 18(1):9. PubMed ID: 31931816
[TBL] [Abstract][Full Text] [Related]
36. Effect of pleural invasion on survival of patients with small cell lung cancer: Propensity score analysis and nomogram establishment based on the SEER database.
Yang J; Yin H; Liu M; Zou G; Yu B
Front Surg; 2023; 10():1108732. PubMed ID: 36911624
[TBL] [Abstract][Full Text] [Related]
37. Monitoring early dynamic changes of plasma cell-free DNA and pretreatment pre-albumin to predict chemotherapy effectiveness and survival outcomes in advanced non-small cell lung cancer.
Chen J; Shao J; Zhang X; Wei S; Cai H; Wang G
Ann Transl Med; 2022 Mar; 10(5):253. PubMed ID: 35402598
[TBL] [Abstract][Full Text] [Related]
38. [Analysis of Correlation between TTF-1 and Sensitivity to First-line Chemotherapy and Prognosis in Patients with Small Cell Lung Cancer].
Wang B; Feng N; Shi X; Qi Q; Chi X; Song T; Li H
Zhongguo Fei Ai Za Zhi; 2020 Jul; 23(7):547-553. PubMed ID: 32702788
[TBL] [Abstract][Full Text] [Related]
39. The combination of plasma fibrinogen and neutrophil lymphocyte ratio (F-NLR) is a predictive factor in patients with resectable non small cell lung cancer.
Wang H; Zhao J; Zhang M; Han L; Wang M; Xingde L
J Cell Physiol; 2018 May; 233(5):4216-4224. PubMed ID: 29057536
[TBL] [Abstract][Full Text] [Related]
40. Fibrinogen/albumin ratio as a promising predictor of platinum response and survival in ovarian clear cell carcinoma.
Chen W; Shan B; Zhou S; Yang H; Ye S
BMC Cancer; 2022 Jan; 22(1):92. PubMed ID: 35062908
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
